Business Context and Reporting Period
Company: ZIMMER BIOMET HOLDINGS, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: March 19, 2018
Event: Completion of a public offering of debt securities.
Key Financial Metrics and Debt Obligations
The filing details the issuance of $750,000,000 in aggregate principal amount of notes, consisting of two tranches:
- Floating Rate Notes due 2021: $450,000,000 aggregate principal amount. Interest accrues at three-month LIBOR plus 0.750%, payable quarterly. Matures March 19, 2021.
- Fixed Rate Notes due 2023: $300,000,000 aggregate principal amount. Interest rate is 3.700% per annum, payable semi-annually. Matures March 19, 2023.
Liquidity and Cash Flow: The filing does not provide specific cash flow, revenue, or liquidity metrics. Proceeds from the offering are intended to be used for general corporate purposes, though specific allocation is not detailed in this text.
Material Changes and Terms
This filing represents a material increase in the Company's direct financial obligations. Key terms include:
- Redemption Rights (Floating Rate): Not redeemable prior to March 20, 2019. Thereafter, redeemable at 100% of principal plus accrued interest.
- Redemption Rights (Fixed Rate): Prior to February 19, 2023, redeemable at the greater of 100% of principal or the present value of remaining payments discounted at the treasury rate plus 20 basis points. After February 19, 2023, redeemable at 100% of principal plus accrued interest.
- Change of Control: If a Change of Control Repurchase Event occurs, the Company must offer to repurchase notes at 101% of the aggregate principal amount plus accrued interest.
- Events of Default: Include nonpayment, failure to comply with covenants for 60 days after notice, and bankruptcy/insolvency events.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the completion of the offering pursuant to a Registration Statement on Form S-3. No forward-looking guidance or outlook regarding future earnings or operations is provided in this specific document.
Risks and Contingencies: The primary risk disclosed is the creation of new debt obligations subject to customary covenants and events of default. The Floating Rate Notes expose the Company to interest rate risk tied to LIBOR.
Investor Verification Checklist
- Verify the use of proceeds from the $750 million offering in subsequent financial reports.
- Monitor the Company's debt-to-equity ratio and interest coverage ratio following this issuance.
- Review the full text of the Fifth Supplemental Indenture (Exhibit 4.2) for specific negative covenants and financial maintenance requirements.
- Track LIBOR fluctuations to assess the variable interest expense on the 2021 notes.